These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37252318)

  • 1. Indolent T-lymphoblastic proliferation with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma: a case report.
    Han W; Wang B; Yong X; Zhang Y; Shao M; Wang C
    Pathol Oncol Res; 2023; 29():1611151. PubMed ID: 37252318
    [No Abstract]   [Full Text] [Related]  

  • 2. Indolent T-lymphoblastic proliferation concomitant with acinic cell carcinoma mimicking T-lymphoblastic lymphoma: case report and literature review.
    Yasuda H; Tsutsui M; Ota Y; Tanaka M; Komatsu N
    Histopathology; 2018 Apr; 72(5):862-866. PubMed ID: 29143359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indolent T-lymphoblastic proliferation involving hepatocellular carcinoma-presentation in novel settings and comprehensive review of literature.
    Ghezavati A; Liang CA; Mais D; Nazarullah A
    J Hematop; 2023 Sep; 16(3):167-175. PubMed ID: 38175402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LIM domain only 2 (LMO2) expression distinguishes T-lymphoblastic leukemia/lymphoma from indolent T-lymphoblastic proliferations.
    Brar N; Butzmann A; Kumar J; Peerani R; Morgan EA; Grigoriadis G; Kumar B; Tatarczuch RM; Warnke RA; Ohgami RS
    Histopathology; 2020 Dec; 77(6):984-988. PubMed ID: 32526041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indolent T-lymphoblastic proliferation (iT-LBP): a review of clinical and pathologic features and distinction from malignant T-lymphoblastic lymphoma.
    Ohgami RS; Arber DA; Zehnder JL; Natkunam Y; Warnke RA
    Adv Anat Pathol; 2013 May; 20(3):137-40. PubMed ID: 23574769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indolent T-lymphoblastic proliferation: a report of three cases.
    Yuanyuan Z; Jianlan X; Yanlin Z; Xiaoge Z
    Virchows Arch; 2022 May; 480(5):1121-1126. PubMed ID: 34482472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indolent T-lymphoblastic proliferation associated with Castleman disease and low grade follicular dendric cell sarcoma: report of a case and review of literature.
    Chen J; Feng J; Xiao H; Ma Q; Chen Z
    Int J Clin Exp Pathol; 2019; 12(4):1497-1505. PubMed ID: 31933967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma with immature T-cell (T-lymphoblastic) proliferation.
    Eun S; Jeon YK; Jang JJ
    J Korean Med Sci; 2010 Feb; 25(2):309-12. PubMed ID: 20119589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric features of incidental indolent T lymphoblastic proliferations.
    Fromm JR; Edlefsen KL; Cherian S; Wood BL; Soma L; Wu D
    Cytometry B Clin Cytom; 2020 May; 98(3):282-287. PubMed ID: 31571375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indolent T-lymphblastic proliferation: report of a case involving the upper aerodigestive tract.
    Yang F; Liu T; Zhao H; Hu Z; Xiao L; Liu Y; Wang X; Li Z
    Int J Clin Exp Pathol; 2014; 7(9):6350-6. PubMed ID: 25337290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indolent T-lymphoblastic proliferation: A systematic review of the literature analyzing the epidemiologic, clinical, and pathologic features of 45 cases.
    Saglam A; Singh K; Gollapudi S; Kumar J; Brar N; Butzmann A; Warnke R; Ohgami RS
    Int J Lab Hematol; 2022 Aug; 44(4):700-711. PubMed ID: 35577551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. sTRBC1 and cyTRBC1 Expression Distinguishes Indolent T-Lymphoblastic Proliferations From T-Lymphoblastic Leukemia/Lymphoma.
    Liu J; Li M; Fu J; Dong M; Fan X; Zhong L; Xu G; Li Y; Xi Q
    Am J Surg Pathol; 2023 Nov; 47(11):1325-1331. PubMed ID: 37515427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic carcinoma with indolent T-lymphoblastic proliferation (iT-LBP).
    Kong M; Wang Z; Teng X; Xu L; Liu J; Jiang C; Teng L
    Int J Clin Exp Pathol; 2018; 11(3):1674-1678. PubMed ID: 31938268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [76-year-old patient with adenocarcinoma of the rectum and fibrolamellar hepatocellular 2d carcinoma. Case report with literature review of hepatocellular carcinoma of the fibrolamellar type].
    Klimpfinger M; Jatzko G; Trink A; Samec HJ; Gaugg A
    Wien Klin Wochenschr; 1987 Jul; 99(14):505-9. PubMed ID: 2820156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exuberant cortical thymocyte proliferation mimicking T-lymphoblastic lymphoma within recurrent large inguinal lymph node masses of localized Castleman disease.
    Kansal R; Nathwani BN; Yiakoumis X; Moschogiannis M; Sachanas S; Stefanaki K; Pangalis GA
    Hum Pathol; 2015 Jul; 46(7):1057-61. PubMed ID: 25953658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological Features of Two Extremely Rare Hepatocellular Carcinoma Variants: a Brief Review of Fibrolamellar and Scirrhous Hepatocellular Carcinoma.
    Samdanci ET; Akatli AN; Soylu NK
    J Gastrointest Cancer; 2020 Dec; 51(4):1187-1192. PubMed ID: 32860202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrolamellar hepatocellular carcinoma arising in a background of focal nodular hyperplasia: a report of 2 cases.
    Imkie M; Myers SA; Li Y; Fan F; Bennett TL; Forster J; Tawfik O
    J Reprod Med; 2005 Aug; 50(8):633-7. PubMed ID: 16220774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indolent T-lymphoblastic proliferation with disseminated multinodal involvement and partial CD33 expression.
    Ohgami RS; Sendamarai AK; Atwater SK; Liedtke M; Fleming MD; Natkunam Y; Warnke RA
    Am J Surg Pathol; 2014 Sep; 38(9):1298-304. PubMed ID: 24618611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis.
    Kakar S; Burgart LJ; Batts KP; Garcia J; Jain D; Ferrell LD
    Mod Pathol; 2005 Nov; 18(11):1417-23. PubMed ID: 15920538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma with indolent T-lymphoblastic proliferation.
    Wang ZM; Xiao WB; Zheng SS; Sun K; Wang LJ
    Leuk Lymphoma; 2006 Nov; 47(11):2424-6. PubMed ID: 17107923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.